Our partner is dedicated to developing therapies for neurological diseases, with a strong focus on conditions like Alzheimer's, multiple sclerosis, and spinal muscular atrophy. Their innovative treatments aim to address critical unmet medical needs and improve the lives of patients living with these challenging conditions.

This critical hire led R&D efforts, overseeing the discovery and development of early and late-stage compounds, including GMP and radiochemistry optimization for preclinical and clinical studies. With at least 5 years of progressive managerial experience in life sciences, the role required expertise in product development and successful FDA submissions. The ideal candidate possessed strong leadership skills and an entrepreneurial spirit, thriving in a collaborative, pre-IPO environment.